Tag: days sales outstanding

Two Blood Brothers Report Declines in Revenue-Per-Req

REIMBURSEMENT FOR CLINICAL laboratory testing has declined, particularly for molecular tests. As a consequence, the nation’s two largest laboratory testing companies are feeling the negative effect of lower lab test prices.

Both Quest Diagnostics Incorporated and Laboratory Corporation of America issued their third quarter earnings reports last week. Their respective performances provide insights into several unfolding

View Article

Spectrum Owns MEDex, Comments on Trends

CEO SUMMARY: Spectrum Laboratory Network recently completed its acquisition of MEDex Laboratories, Inc. of Kingsport, Tennessee. It is becoming a regional laboratory powerhouse, challenging Laboratory Corporation of America in North Carolina and establishing a sales base in Atlanta, long-dominated by Quest Diagnostics Incorporated. It is also adding managed care contracts.


View Article

20% Medicare Co-Pay A Blow to Regional Labs

CEO SUMMARY: Informed speculation indicates that private health insurers are likely to adopt some form of laboratory test co-payment if the proposed Medicare 20% lab test co-pay legislation becomes law. For hospital laboratory outreach programs, the resulting reduction of reimbursement and associated higher costs of billing small amounts to patients would prove to be financially

View Article

Are Two Blood Brothers Using Economic Clout?

CEO SUMMARY: Quest Diagnostics Incorporated and Laboratory Corporation of America now dominate the national marketplace for testing referred by physicians’ offices. Release of their second quarter earnings reports provides the first look at their performance following the acquisitions in 2002 which removed American Medical Laboratories, Dynacare, DIANON Systems, and Unilab from the marketplace.


View Article

Specialty Laboratories, IMPATH, Roche, Abbott Laboratories, Celera Diagnostics

IT’S NO SURPRISE THAT COMPETITORS of Specialty Laboratories, Inc. have been willing to spread a variety of rumors about the laboratory company, given its well-publicized troubles with government regulators last year.

Notwithstanding these rumors, the reality at Specialty Labs is quite different. On April 24, the company, based in Santa

View Article